XML 87 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 05, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-38085    
Entity Registrant Name Ovid Therapeutics Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 46-5270895    
Entity Address, Address Line One 441 Ninth Avenue    
Entity Address, Address Line Two 14th Floor    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10001    
City Area Code 646    
Local Phone Number 661-7661    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol OVID    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 191.1
Entity Common Stock, Shares Outstanding   70,709,857  
Documents Incorporated by Reference
Portions of the registrant’s definitive proxy statement for its 2024 Annual Meeting of Stockholders, which the registrant intends to file pursuant to Regulation 14A with the Securities and Exchange Commission not later than 120 days after the registrant’s fiscal year ended December 31, 2023, are incorporated by reference into Part III of this Annual Report on Form 10-K.
    
Amendment Flag false    
Entity Central Index Key 0001636651    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY